This suggests that K-ras and p53 alterations mostly coexist in pancreatic adenocarcinoma, but alterations in these genes are on independent pathways to pancreatic adenocarcinoma and are not in a common way of cumulative gene variation. The gene discussed is TP53; the disease is pancreatic adenocarcinoma.